Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05980442

Comparative Study of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee Arthroplasty

Randomized, controlled, single center observational study to compare the safety and performance of navigation-assisted OrthoPilot Elite and robotic-assisted MAKO total knee arthroplasty (TKA). The aim of the study is the comparison of the clinical outcome between navigated and robotic-assisted TKA. The hypothesis of the study is that both treatments achieve similar results regarding functional and clinical aspects.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Bundeswehr Krankenhaus Ulm

Ulm, Baden-Wurttemberg, 89081, Germany

Location status: Recruiting

Location contact

Hans-Joachim Riesner, PD Dr. med.

CONTACT

Hans-Joachim Riesner, PD Dr. med.

PRINCIPAL_INVESTIGATOR

Jörg Schneider, Dr. med.

CONTACT

Jörg Schneider, Dr. med.

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Indication for a TKA with a fixed-bearing total knee endoprosthesis
  • Written informed consent for participating in the clinical study

Exclusion criteria

  • Patient age <18 years and >90 years
  • Patient not willing to participate at the follow-up
  • Pregnancy
  • retropatellar arthrosis requiring patella resurfacing
  • American Society of Anaesthesiologists (ASA) Classification >3

Treatment and study plan

Navigated total knee arthroplasty

Device

Total knee arthroplasty with Columbus® total knee endoprosthesis using the OrthoPilot® Elite navigation system

Other names: Columbus® total knee endoprosthesis

Robot assisted total knee arthroplasty

Device

Total knee arthroplasty with Triathlon® total knee endoprosthesis using the MAKO® robot system

Other names: Triathlon® total knee endoprosthesis

Primary outcomes

  1. Functional outcome of the Knee Surgery measured by the Knee Society Score (KSS) (functional component)

    Time frame: one year postoperatively

    Functional result one year postoperatively measured with the functional component of the Knee Society Score (KSS). The KSS is an examiner-administrated standard clinical evaluation tool reporting results for patients undergoing TKA.

    It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.

Secondary outcomes

  1. Survival of the implant components

    Time frame: one year postoperatively

    Kaplan-Meier Analysis is a standard statistical method to describe the survival of human subjects or medical products over a defined time period. The revision-free survival rate is the performance indicator of the product under investigation and confirms the clinical outcome of the knee prosthesis. Information on survival of the implant will be collected.

  2. Clinical outcome of the Knee Surgery measured by the Knee Society Score (KSS) (clinical component)

    Time frame: one year postoperatively

    Functional result one year postoperatively measured with the functional component of the Knee Society Score (KSS). The KSS is an examiner-administrated standard clinical evaluation tool reporting results for patients undergoing TKA.

    It separates findings in the operated knee (kKSS) score from findings related to the patient's function (fKSS), which might be affected by co-morbidities. The two sub-scores are reported separately ranging from 0 points (worst result) to 100 points (best results), as well as summarized score, total KSS. Final grading of total KSS results Scores of 160 to 200 will be rated as excellent, 140 to 159 as good, 120 to 139 as fair, and less than 120 as poor.

  3. Quality of Life [EQ-5D-5L]

    Time frame: one year postoperatively

    EQ-5D is a standardized 5-dimension (5D) 5-level (5L) measure of the health status and is developed by the EuroQol Group in order to have a simple and generic measure for clinical and economic assessment. Instructions for the user are directly included into the questionnaire and it consists of two pages. One cover five different dimensions (mobility, self care, usual activities, pain/discomfort, anxiety/depression) and the other one the EQ visual Analogue Scale (EQ-VAS). The VAS scale records the self rated health status of the patient from the level "the worst health you can imagine" to "the best health you can imagine".

  4. Anterior knee pain

    Time frame: one year postoperatively

    Anterior knee pain is used to evaluate the performance of the implantation and the implant itself. Rating is classified according to the description of Waters and Bentley in four dimensions: 0 (no pain), I (Mild pain that does not intrude on daily activities), II (Moderate pain that is a nuisance; patient not considering further surgery), III (Severe pain; Patient considering further surgery). The scoring is according to Feller et al. 0, 5, 10 and 15 points, respectively.

  5. Comparison of Radiographic alignment

    Time frame: one year postoperatively

    Alignment (femoral-knee baseline angle, tibial-knee baseline angle, femoral-tibial angle (mechanical))

  6. Comparison of Radiographic status

    Time frame: one year postoperatively

    potential presence of radiolucency at the interface between implant and bone on femoral and tibial components will be analyzed

  7. (Serious) Adverse Events

    Time frame: During the course of the study up to one year postoperatively

    During the course of the study, any upcoming intra- or postoperative (serious) adverse device events or effects ((S)AE) related or not related to the product under investigation, will be documented. The total number of (S)AEs will be summarized and further evaluated by the sponsor and reported according to local legislation and necessity. Recorded complications will be categorized and analyzed in order to assess the safety of the investigational product.

Study contacts

Contact information is provided by the study sponsor or research team.

Kristin Maier, Dr.

CONTACT

[email protected]

+49746195

Marius Selig

CONTACT

[email protected]

+49746195

Sponsors and collaborators

Lead sponsor

Aesculap AG

Industry

Registry information

Official study title

Randomized, Controlled, Single Center Observational Study to Compare the Safety and Performance of Navigation-assisted OrthoPilot® Elite and Robotic-assisted MAKO® Total Knee Arthroplasty

Acronym: ORMAK

Important dates

Study start
2024
Primary completion
2027
Study completion
2028
First posted
Aug 8, 2023
Registry last updated
Mar 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.